Fortive Corp

FTV 10-Q · Q2 2025

FTV Q2 2025 request

Playground key active
Request URL /api/financials?ticker=FTV&year=2025&quarter=2
waiting 0 ms
Pick an endpoint and run the request.
curl

Income Statement

Income Statement
Metric Q2 2025 Q2 2024 YoY
Revenue 1,518.8 1,552.4 -2.2%
Show Product Lines breakouts
Product 1,277.4 1,308.9 -2.4%
Product · Advanced Healthcare Solutions 249.9 255.3 -2.1%
Product · Intelligent Operating Solutions 562.5 563.3 -0.1%
Product · Precision Technologies 465 490.3 -5.2%
Service 241.4 243.5 -0.9%
Service · Advanced Healthcare Solutions 69.6 68.3 +1.9%
Service · Intelligent Operating Solutions 113.2 113.7 -0.4%
Service · Precision Technologies 58.6 61.5 -4.7%
Show Business Segments breakouts
Advanced Healthcare Solutions · All other 114.1 119.8 -4.8%
Advanced Healthcare Solutions · CN 24.6 25.3 -2.8%
Advanced Healthcare Solutions · Distributors 3.4 3.4 0.0%
Advanced Healthcare Solutions · Government 9.1 9.3 -2.2%
Advanced Healthcare Solutions · Health Care 302.5 306.3 -1.2%
Advanced Healthcare Solutions · Industrial & Manufacturing 4.5 4.6 -2.2%
Advanced Healthcare Solutions · Operating Segments 319.5 323.6 -1.3%
Advanced Healthcare Solutions · Total direct sales 316.1 320.2 -1.3%
Advanced Healthcare Solutions · US 180.8 178.5 +1.3%
Intelligent Operating Solutions · Aerospace & Defense 0.1 0.1 0.0%
Intelligent Operating Solutions · All other 246.3 243 +1.4%
Intelligent Operating Solutions · CN 49.5 53.2 -7.0%
Intelligent Operating Solutions · Communications, Electronics & Semiconductor 28.5 25.5 +11.8%
Intelligent Operating Solutions · Distributors 35.3 40.4 -12.6%
Intelligent Operating Solutions · Government 79.6 80.3 -0.9%
Intelligent Operating Solutions · Health Care 10.6 11.1 -4.5%
Intelligent Operating Solutions · Industrial & Manufacturing 231.3 236 -2.0%
Intelligent Operating Solutions · Oil And Gas 71.2 69.3 +2.7%
Intelligent Operating Solutions · Operating Segments 675.7 677 -0.2%
Intelligent Operating Solutions · Other 100.2 100 +0.2%
Intelligent Operating Solutions · Retail & Consumer 70.5 65.5 +7.6%
Intelligent Operating Solutions · Total direct sales 640.4 636.6 +0.6%
Intelligent Operating Solutions · US 379.9 380.8 -0.2%
Intelligent Operating Solutions · Utilities & Power 48.4 48.8 -0.8%
Precision Technologies · Aerospace & Defense 78.9 83.3 -5.3%
Precision Technologies · All other 173.5 184.2 -5.8%
Precision Technologies · CN 85.6 86.6 -1.2%
Precision Technologies · Communications, Electronics & Semiconductor 55.8 69 -19.1%
Precision Technologies · Distributors 44.8 57.2 -21.7%
Precision Technologies · Government 44.3 52.6 -15.8%
Precision Technologies · Health Care 46.9 51.5 -8.9%
Precision Technologies · Industrial & Manufacturing 93.7 89.1 +5.2%
Precision Technologies · Oil And Gas 2.2 2.8 -21.4%
Precision Technologies · Operating Segments 523.6 551.8 -5.1%
Precision Technologies · Operating Segments 523.6 551.8 -5.1%
Precision Technologies · Other 66 75.9 -13.0%
Precision Technologies · Retail & Consumer 24.5 15.1 +62.3%
Precision Technologies · Total direct sales 478.8 494.6 -3.2%
Precision Technologies · US 264.5 281 -5.9%
Precision Technologies · Utilities & Power 66.5 55.3 +20.3%
Show Geography breakouts
All other 533.9 547 -2.4%
CN 159.7 165.1 -3.3%
US 825.2 840.3 -1.8%
Show End Market [Axis] breakouts
Aerospace & Defense 79 83.4 -5.3%
Communications, Electronics & Semiconductor 84.3 94.5 -10.8%
Distributors 83.5 101 -17.3%
Government 133 142.2 -6.5%
Health Care 360 368.9 -2.4%
Industrial & Manufacturing 329.5 329.7 -0.1%
Oil And Gas 73.4 72.1 +1.8%
Other 166.2 175.9 -5.5%
Retail & Consumer 95 80.6 +17.9%
Total direct sales 1,435.3 1,451.4 -1.1%
Utilities & Power 114.9 104.1 +10.4%
Cost of Revenue -623.1 -624.1 +0.2%
Show Product Lines breakouts
Product -503.5 -500.2 -0.7%
Service -119.6 -123.9 +3.5%
Show Business Segments breakouts
Advanced Healthcare Solutions · Operating Segments -130 -136.1 +4.5%
Intelligent Operating Solutions · Operating Segments -231.8 -221.7 -4.6%
Precision Technologies · Operating Segments -261.3 -266.3 +1.9%
Gross Profit 895.7 928.3 -3.5%
Show Business Segments breakouts
Advanced Healthcare Solutions · Operating Segments 189.5 187.5 +1.1%
Intelligent Operating Solutions · Operating Segments 443.9 455.3 -2.5%
Precision Technologies · Operating Segments 262.3 285.5 -8.1%
Selling, General & Administrative -564.3 -525.4 -7.4%
Research & Development -109.2 -101.1 -8.0%
Operating Income 222.2 301.8 -26.4%
Show Business Segments breakouts
Advanced Healthcare Solutions · Operating Segments 39.1 40.2 -2.7%
Corporate And Other · Corporate Non Segment -76.8 -26.9 -185.5%
Intelligent Operating Solutions · Operating Segments 166.7 173.2 -3.8%
Precision Technologies · Operating Segments 93.2 115.3 -19.2%
Interest Expense -32.1 -38.7 +17.1%
Other Non-Operating Income (Expense) 1.9 -8.8 +121.6%
Show Business Segments breakouts
Corporate And Other · Corporate Non Segment 1.9 -8.8 +121.6%
Income Before Taxes 192 228.7 -16.0%
Show Business Segments breakouts
Advanced Healthcare Solutions · Operating Segments 39.1 40.2 -2.7%
Corporate And Other · Corporate Non Segment -107 -100 -7.0%
Intelligent Operating Solutions · Operating Segments 166.7 173.2 -3.8%
Precision Technologies · Operating Segments 93.2 115.3 -19.2%
Income Tax Expense (Benefit) -25.4 -33.6 +24.4%
Net Income 166.6 195.1 -14.6%
Show Equity Components breakouts
Retained Earnings 166.6 207.4 -19.7%
EPS (Basic) 0.49 0.56 -12.5%
EPS (Diluted) 0.49 0.55 -10.9%
Wtd Avg Shares (Basic) 339.6 351.3 -3.3%
Wtd Avg Shares (Diluted) 341.7 354.8 -3.7%
Operating Expenses -673.5 -626.5 -7.5%
Show Business Segments breakouts
Advanced Healthcare Solutions · Operating Segments -150.4 -147.3 -2.1%
Corporate And Other · Corporate Non Segment -76.8 -26.9 -185.5%
Intelligent Operating Solutions · Operating Segments -277.2 -282.1 +1.7%
Precision Technologies · Operating Segments -169.1 -170.2 +0.6%
Comprehensive Income 274.6 174 +57.8%
Other Comprehensive Income 108 -21.1 +611.8%
Show Equity Components breakouts
Accumulated Other Comprehensive Income 108 -76.4 +241.4%
Interest Expense -32.1 -38.7 +17.1%
Show Business Segments breakouts
Corporate And Other · Corporate Non Segment -32.1 -38.7 +17.1%

Balance Sheet

Balance Sheet
Metric Q2 2025 Q2 2024 YoY
Current Assets
Cash & Cash Equivalents 1,832.7 644.1 +184.5%
Accounts Receivable 912.2 934.5 -2.4%
Inventory Finished Goods Net Of Reserves 257.3 224 +14.9%
Inventory Work In Process Net Of Reserves 117 116.1 +0.8%
Inventory Raw Materials Net Of Reserves 236.1 231.9 +1.8%
Inventory 610.4 572 +6.7%
Prepaid Expenses & Other Current Assets 328.1 368.9 -11.1%
Total Current Assets 3,683.4 2,519.5 +46.2%
Non-Current Assets
Property, Plant & Equipment 447.9 417.9 +7.2%
Other Non-Current Assets 509.3 540 -5.7%
Goodwill 10,403.7
Show Business Segments breakouts
Advanced Healthcare Solutions 3,115.7
Intelligent Operating Solutions 4,168.9
Precision Technologies 3,119.1
Total Assets 18,244.2
Show Business Segments breakouts
Advanced Healthcare Solutions · Operating Segments 4,947.1
Intelligent Operating Solutions · Operating Segments 6,343.2
Precision Technologies · Operating Segments 4,947.6
Show Consolidation Items breakouts
Corporate Non Segment 2,006.3
Operating Segments 16,237.9
Operating Lease Right-of-Use Assets 159.3
Other Assets
Intangible Assets Net Excluding Goodwill 3,199.9 3,591.1 -10.9%
Current Liabilities
Current Portion of Long-Term Debt 1,905.7
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level1 1,905.7
Accounts Payable Trade Current 700.5 636.1 +10.1%
Accrued Liabilities 1,139.4 1,025.8 +11.1%
Total Current Liabilities 3,745.6 2,045.8 +83.1%
Deferred Revenue (Current) 565.9
Non-Current Liabilities
Other Non-Current Liabilities 1,202.9 1,337 -10.0%
Long-Term Debt 2,906.5
Long-Term Debt 4,812.2
Show Debt Instrument breakouts
U.S. dollar-denominated commercial paper · Commercial Paper 394.2
Contract With Customer Liability Noncurrent 62.4
Other Liabilities
Minority Interest 7.1 6.5 +9.2%
Stockholders' Equity
Common Stock 3.7 3.7 0.0%
Additional Paid-In Capital 4,106 3,937.3 +4.3%
Treasury Stock Common Value -1,952.2 -870.4 -124.3%
Retained Earnings 8,511.9 7,852.3 +8.4%
Accumulated Other Comprehensive Income -287.3 -423.6 +32.2%
Total Stockholders' Equity 10,382.1 10,499.3 -1.1%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 10,389.2
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment -34 -34.3 +0.9%
Accumulated Other Comprehensive Income -287.3 -423.6 +32.2%
Accumulated Translation Adjustment -253.3 -389.3 +34.9%
Additional Paid In Capital 4,106 3,937.3 +4.3%
Common Stock 3.7 3.7 0.0%
Noncontrolling Interest 7.1 6.5 +9.2%
Retained Earnings 8,511.9 7,852.3 +8.4%
Treasury Stock Common -1,952.2 -870.4 -124.3%
Total Liabilities & Equity 18,244.2 17,285 +5.5%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q2 2025 YTD Q2 2024 YoY
Operating Activities
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest 338.5 402.5 -15.9%
Adjustment For Amortization 225 227.1 -0.9%
Depreciation 47.7 46.2 +3.2%
Stock-Based Compensation 54.9 53.1 +3.4%
Change in Accounts Receivable 75.5 24.6 +206.9%
Change in Inventory -57.7 -12 -380.8%
Change in Accounts Payable 13.8 30.7 -55.0%
Change in Prepaid & Other Assets -40.3 -11.5 -250.4%
Increase Decrease In Accrued Liabilities -104.5 -157.6 +33.7%
Net Cash from Operations 552.9 565.6 -2.2%
Depreciation & Amortization -272.7 -273.3 +0.2%
Show Business Segments breakouts
Advanced Healthcare Solutions · Operating Segments -99.9 -100.5 +0.6%
Corporate And Other · Corporate Non Segment -0.6 -0.2 -200.0%
Intelligent Operating Solutions · Operating Segments -116.3 -114.4 -1.7%
Precision Technologies · Operating Segments -55.9 -58.2 +4.0%
Investing Activities
Capital Expenditures -63.4 -55.6 -14.0%
Proceeds From Sale Of Other Assets Investing Activities 1.7 10.8 -84.3%
Other Investing Activities 10.9 -1.6 +781.2%
Net Cash from Investing -50.8 -1,782.2 +97.1%
Financing Activities
Proceeds From Repayments Of Commercial Paper -253.2 -571.5 +55.7%
Share Repurchases -344.5 -152.9 -125.3%
Payments Of Dividends Common Stock -54.2 -56.1 +3.4%
Proceeds From Debt Maturing In More Than Three Months 1,146.8 1,733.5 -33.8%
Proceeds From Payments For Other Financing Activities 14.4 31.9 -54.9%
Net Cash from Financing 509.3 -15.1 +3472.8%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 8 -13 +161.5%
Net Change in Cash 1,019.4 -1,244.7 +181.9%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1,832.7 644.1 +184.5%

Values in millions USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key